Long-acting β(2)-agonists (LABA) in chronic obstructive pulmonary disease: efficacy and safety

COPD is characterized by progressive airflow obstruction which does not fully reverse to inhaled or oral pharmacotherapy. The management of patients with COPD has taken a totally new direction over the past 20 years, thank to the use of novel therapies aimed to improve and modify the natural history...

Descripción completa

Detalles Bibliográficos
Autores principales: Rossi, Andrea, Khirani, Sonia, Cazzola, Mario
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2650610/
https://www.ncbi.nlm.nih.gov/pubmed/19281071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2650610/
https://www.ncbi.nlm.nih.gov/pubmed/19281071

Ejemplares similares